Researchers at Duke Cancer Institute believe they have pinpointed why PSA (prostate-specific antigen) levels reflect cancer progression.

Interstitial brachytherapy may or may not hold advantages compared to other therapy options in men with localized prostate cancer, according to a new study.

The cancer drug cisplatin can be more effectively administered once encapsulated in a nanoparticle that targets prostate tumor cells and activates upon arrival.

Physical activity may play a vital role in longevity in men with prostate cancer, according to a new study from Harvard School of Public Health and the University of California, San Francisco.